-+ 0.00%
-+ 0.00%
-+ 0.00%

Ensysce Biosciences Has Been Granted European Patent Number EP3934635 Titled "COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF (FOR THE TREATMENT OR PREVENTION OF ATTENTION DEFICIT DISORDER (ADHD))"

Benzinga·05/20/2026 19:59:45
Listen to the news